Literature DB >> 18049836

Chromosome X modulates incidence of testicular germ cell tumors in Ter mice.

Shirley Hammond1, Rui Zhu, Kirsten K Youngren, Josephine Lam, Philip Anderson, Angabin Matin.   

Abstract

Germ cell tumor development in humans has been proposed to be part of testicular dysgenesis syndrome (TDS), which manifests as undescended testes, sterility, hypospadias, and, in extreme cases, as germ cell tumors. Males of the Ter mouse strain show interesting parallels to TDS because they either lack germ cells and are sterile or develop testicular germ cell tumors. We found that these defects in Ter mice are due to mutational inactivation of the Dead-end (Dnd1) gene. Here we report that chromosome X modulates germ cell tumor development in Ter mice. We tested whether the X or the Y chromosome influences tumor incidence. We used chromosome substitution strains to generate two new mouse strains: 129-Ter/Ter that carry either a C57BL/6J (B6)-derived chromosome (Chr) X or Y. We found that Ter/Ter males with B6-Chr X, but not B6-Chr Y, showed a significant shift in propensity from testicular tumor development to sterile testes phenotype. Thus, our studies provide unambiguous evidence that genetic factors from Chr X modulate the incidence of germ cell tumors in mice with inactivated Dnd1.

Entities:  

Mesh:

Year:  2007        PMID: 18049836      PMCID: PMC2647741          DOI: 10.1007/s00335-007-9075-8

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  25 in total

1.  Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours.

Authors:  E A Rapley; G P Crockford; D Teare; P Biggs; S Seal; R Barfoot; S Edwards; R Hamoudi; K Heimdal; S D Fossâ; K Tucker; J Donald; F Collins; M Friedlander; D Hogg; P Goss; A Heidenreich; W Ormiston; P A Daly; D Forman; T D Oliver; M Leahy; R Huddart; C S Cooper; J G Bodmer; D F Easton; M R Stratton; D T Bishop
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

Review 2.  Analysing complex genetic traits with chromosome substitution strains.

Authors:  J H Nadeau; J B Singer; A Matin; E S Lander
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  Re-analysis of the Xq27-Xq28 region suggests a weak association of an X-linked gene with sporadic testicular germ cell tumour without cryptorchidism.

Authors:  M F Lutke Holzik; H J Hoekstra; R H Sijmons; D J A Sonneveld; G van der Steege; D Th Sleijfer; I M Nolte
Journal:  Eur J Cancer       Date:  2006-06-22       Impact factor: 9.162

4.  Genome-wide linkage screen for testicular germ cell tumour susceptibility loci.

Authors:  Gillian P Crockford; Rachel Linger; Sarah Hockley; Darshna Dudakia; Lola Johnson; Robert Huddart; Kathy Tucker; Michael Friedlander; Kelly-Anne Phillips; David Hogg; Michael A S Jewett; Radka Lohynska; Gedske Daugaard; Stéphane Richard; Agnes Chompret; Catherine Bonaïti-Pellié; Axel Heidenreich; Peter Albers; Edith Olah; Lajos Geczi; Istvan Bodrogi; Wilma J Ormiston; Peter A Daly; Parry Guilford; Sophie D Fosså; Ketil Heimdal; Sergei A Tjulandin; Ludmila Liubchenko; Hans Stoll; Walter Weber; David Forman; Timothy Oliver; Lawrence Einhorn; Mary McMaster; Joan Kramer; Mark H Greene; Barbara L Weber; Katherine L Nathanson; Victoria Cortessis; Douglas F Easton; D Timothy Bishop; Michael R Stratton; Elizabeth A Rapley
Journal:  Hum Mol Genet       Date:  2006-01-11       Impact factor: 6.150

5.  Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain.

Authors:  A Matin; G B Collin; Y Asada; D Varnum; J H Nadeau
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

6.  The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours.

Authors:  Kirsten K Youngren; Douglas Coveney; Xiaoning Peng; Chitralekha Bhattacharya; Laura S Schmidt; Michael L Nickerson; Bruce T Lamb; Jian Min Deng; Richard R Behringer; Blanche Capel; Edward M Rubin; Joseph H Nadeau; Angabin Matin
Journal:  Nature       Date:  2005-05-19       Impact factor: 49.962

Review 7.  Testicular germ-cell tumours in a broader perspective.

Authors:  J Wolter Oosterhuis; Leendert H J Looijenga
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

8.  Risk of testicular cancer in men with abnormal semen characteristics: cohort study.

Authors:  R Jacobsen; E Bostofte; G Engholm; J Hansen; J H Olsen; N E Skakkebaek; H Moller
Journal:  BMJ       Date:  2000-09-30

Review 9.  Pediatric germ cell tumors.

Authors:  F J Rescorla
Journal:  Semin Surg Oncol       Date:  1999-03

Review 10.  Testicular germ-cell cancer.

Authors:  Alan Horwich; Janet Shipley; Robert Huddart
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

View more
  5 in total

1.  Transgenerational genetic effects of the paternal Y chromosome on daughters' phenotypes.

Authors:  Vicki R Nelson; Sabrina H Spiezio; Joseph H Nadeau
Journal:  Epigenomics       Date:  2010-08       Impact factor: 4.778

2.  The role of the mouse y chromosome on susceptibility to testicular germ cell tumors.

Authors:  Philip D Anderson; Man-Yee Lam; Christophe Poirier; Colin E Bishop; Joseph H Nadeau
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

3.  BAX-mediated cell death affects early germ cell loss and incidence of testicular teratomas in Dnd1(Ter/Ter) mice.

Authors:  Matthew S Cook; Douglas Coveney; Iordan Batchvarov; Joseph H Nadeau; Blanche Capel
Journal:  Dev Biol       Date:  2009-02-06       Impact factor: 3.582

4.  Screening for germline DND1 mutations in testicular cancer patients.

Authors:  Rolf H Sijmons; Yvonne J Vos; Johanna C Herkert; Krista K Bos; Martijn F Lutke Holzik; Josette E H M Hoekstra-Weebers; Robert M W Hofstra; Harald J Hoekstra
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

5.  Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1).

Authors:  Chitralekha Bhattacharya; Sita Aggarwal; Madhu Kumar; Amatul Ali; Angabin Matin
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.